Ȩ > ´ÚÅÍÇÏÆ®¼Ò½Ä

 
¾È³çÇϽʴϱî? ´ÚÅÍÇÏÆ®¿¡¼­ °øÁö»çÇ×À» ¾Ë·Áµå¸³´Ï´Ù.
 
2024. 04. 21.
 ÀÌÁ¾Àå±â ¼¼¹Ì³ª
±Û¾´ÀÌ: °ü¸®ÀÚ  ³¯Â¥: 2009.03.16. 14:45:55   Á¶È¸: 4151

  *** 2009³â 1Â÷ ÀÌÁ¾Àå±â ¼¼¹Ì³ª *** 

ÀϽà :  2009³â 3¿ù 13-14ÀÏ, Àå¼Ò :  Àϸ¶·¹ÆÔÅÚ (ÀÎõ±¤¿ª½Ã Áß±¸ À»¿Õµ¿ 885-1)¿¡¼­ ¸¹Àº ÈäºÎ¿Ü°ú, ÆǸ·°ü·Ã ¿¬±¸¿ø, ±âŸ ÀÇ·á¾÷°è¿¡¼­µµ ¸ðµÎ ¾à 60¸í°¡·®ÀÌ Âü¼®ÇÏ¿´À¸¸ç ¼ºÈ²¸® ¿¬±¸ ¹ßǥȸ°¡ ÁøÇàµÇ¾ú´Ù. 

°­ÀÇ Á¦¸ñÀº Development of xenograft, normal valvular structure, Design of bioprosthesis, Design of valved conduit, Anticalcification treatment (1, II), Glutaraldehyde fixation  & mechanical properties (!, II), Decellularization & tissue engineering, Immunologic approach to remove xenoreactive antigen, Large animal study & evaluation, Zero-pressure fixation, Methods of tissue preservation, Material assessment(1, II)µîÀÇ ¿¬Á¦°¡ ¹ßÇ¥µÇ¾ú´Ù.        

LIST  MODIFY DELETE WRITE  





Àüü±Û ¸ñ·Ï 2024. 04. 21.  Àüü±Û: 211  ¹æ¹®¼ö: 1022762
93 Á¦ 63Â÷ ÀϺ»ÈäºÎ¿Ü°úÇÐȸ °ü¸®ÀÚ2010.10.27.4124
92 ÀÌÁ¾Àå±â ½ÉÇ÷°ü°èÀÌÁ¾À̽ݳ¹ß °ü¸®ÀÚ2010.09.08.4161
91 Áß±¹ ¿¬º¯´ëÇÐ º¹Áöº´¿ø ½ÉÀå¼ö¼ú °ü¸®ÀÚ2010.08.21.4403
90 ¼­¿ï´ëÇб³º´¿øÀå ǥâÆÐ ¼ö¿© °ü¸®ÀÚ2010.08.21.4083
89 Á¦ 3Â÷ ¾Æ½Ã¾Æ-ÅÂÆò¾ç ¼Ò¾Æ½ÉÀåÇÐȸ Çмú´ëȸ °ü¸®ÀÚ2010.07.09.4092
88 Áß±¹ Èæ·æ°­¼º ÇϾóºó ¾Æµ¿º´¿ø ½ÉÀå¼ö¼ú °ü¸®ÀÚ2010.06.20.4273
87 Á¦ 90Â÷ ¹Ì±¹ÈäºÎ¿Ü°úÇÐȸ °ü¸®ÀÚ2010.05.08.4114
86 Áß±¹ ÇϾóºó ¾Æµ¿º´¿ø ½ÉÀå¼ö¼ú °ü¸®ÀÚ2010.04.12.4538
85 Á¦ 18Â÷ ¾Æ½Ã¾Æ ½ÉÀåÇ÷°ü ¹× ÈäºÎ¿Ü°úÇÐȸ °ü¸®ÀÚ2010.03.02.4229
84 Æóµ¿¸Æ °íÇ÷¾Ð 2010 °Ü¿ï½ÉÆ÷Áö¿ò °ü¸®ÀÚ2010.02.01.4259
RELOAD WRITE
 1 ¢¸ 11 [12] [13] [14] [15] [16] [17] [18] [19] [20]  ¢º 22